Enliven Therapeutics, Inc. (ELVN) has a market capitalization of $2.68B and trades at $44.85. The 52-week range is 13.3-40.62.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -24.5, Earnings Per Share (EPS) of $-1.83.
The stock has a beta of 0.49, operates in the Healthcare sector.
